Data Integrity failures remain one of the most common reasons for regulatory action in the pharmaceutical industry and continue to be among the most frequently cited findings in inspections globally. Notably, approximately 60% of these failures could be avoided with the implementation of robust data governance frameworks.
As part of our consulting engagements, SeerPharma is frequently engaged by clients to review and assess their approach to managing Data Integrity. To gain insights into some of our key observations, we invite you to read our article: Data Integrity - Intentional, Unintentional and Potential
In other cases, clients engage us to digitise their Quality Management System (QMS) workflows—helping to address data silos and strengthen oversight of operational activities. Through our partnership with market-leading software platform MasterControl, we support clients in implementing a mature and integrated electronic QMS (eQMS) that enhances visibility and control over critical data processes.
In response to industry demand, SeerPharma Senior Consultant Abraham John and Business Development Manager Anil Pendurthi will host a joint webinar on Wednesday the 16th of July. The session will focus on strengthening Data Integrity through embedded governance and feature a demonstration of key MasterControl functionalities that address common Data Integrity challenges.
This webinar will explore how organisations can shift from reactive compliance to proactive, risk-based practices.
Key topics to be covered include:
Abraham will provide practical guidance on how organisations can:
Anil will provide attendees a brief (10min) overview of how MasterControl helps our clients address DI challenges such as:
Join us for this free webinar on Wednesday, 16 July, to explore best practices in Data Integrity and governance.
This initiative reflects our ongoing mission to Advance Quality and GMP Best-Practices across the Asia-Pacific region for the pharmaceutical and medical device industries.